Cidara Therapeutics, Inc. — Form D

Cidara Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-09-13. The offering totals $9.0M, of which $9.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Daniel D BurgessDirectorSacramento, CA
Timothy R FransonDirectorSan Diego, CA
David R GollaherDirectorSan Diego, CA
Chrysa R MineoDirectorSan Diego, CA
Theodore R SchroederDirectorSan Diego, CA
Jeffrey SteinDirectorSan Francisco, CA
Neil R AbdollahianExecutive OfficerSan Diego, CA
Paul R DaruwalaExecutive OfficerSan Diego, CA
James R LevineExecutive OfficerSan Diego, CA
Jessica R OienExecutive OfficerSan Diego, CA
Taylor R SandisonExecutive OfficerSan Diego, CA
Jeffrey SteinExecutive OfficerSan Francisco, CA
Dirk ThyeExecutive OfficerSouth San Francisco, CA
Carin R Canale-TheakstonDirectorSan Diego, CA
Laura R Tadvalkar, Ph.D.DirectorSan Diego, CA
Taylor R Sandison, M.D.Executive OfficerSan Diego, CA
Leslie R Tari, Ph.D.Executive OfficerSan Diego, CA
Preetam R Shah, Ph.D.Executive OfficerSan Diego, CA
Bonnie R Bassler, Ph.D.DirectorSan Diego, CA
James R Merson, Ph.D.DirectorSan Diego, CA
Ryan R SpencerDirectorSan Diego, CA
Shane R WardExecutive OfficerSan Diego, CA
Jeffrey Stein, Ph.D.DirectorSan Diego, CA
Jeffrey Stein, Ph.D.Executive OfficerSan Diego, CA
Nina KjellsonDirectorSanta Clara, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2024-05-06D$240.0M$240.0M
2018-05-30D$1.9M$1.6M
2017-10-31D$20.2M$20.2M
2015-02-17D$42.0M$42.0M
2014-06-17D$42.7M$30.3M
2014-06-17D$6.0M$6.0M

More